This finding suggests that molecules interfering with AR/FlnA could be used to prevent PC progression and also provide a new option to cut down the metastatic potential of PC cells also targeting tumor microenvironment [6,8]. The gene discussed is FLNA; the disease is pachyonychia congenita.